The Engine of Modern Diagnostics

Discover the smart, secure, and scalable technology that powers RapidTest.AI, turning any smartphone into a clinical-grade diagnostic tool.

Technology in Action

Our computer vision API, running on Edge-AI, delivers rapid and accurate results directly from a smartphone.

RapidTest.AI Align Cassette in Guides S T C ANALYZING... QC Status: Passed ✓ Result: POSITIVE Data Sent EHR/LIS System Patient ID: ****345 Result: POSITIVE ✓ Verified

Advanced Computer Vision Core

Our API leverages sophisticated algorithms to interpret a wide array of lateral-flow tests with high accuracy, assessing color intensity and delivering a result in under 60 seconds. Built-in QC checks ensure reliable readings every time.

Image Capture AI Analysis Secure Result

The Edge-AI Advantage

By processing data directly on the user's device, we enhance data privacy and deliver rapid results. This approach eliminates cloud latency and functions effectively even in low-connectivity environments.

Edge AI (Ours) Cloud AI Fast & Private Slower & Less Private

Assay-Agnostic & Rapid Onboarding

Our platform is designed to be compatible with various test formats including cassettes, strips, and other devices. A single, robust codebase allows us to efficiently onboard new assays in less than 4 weeks, ensuring adaptability and scalability.

Cassette TestDip StripCustom Device

Key Features & Benefits

Rapid Results & Auto-QC

Under 60-second results with automated quality control for lighting and angle.

Secure Data Transmission

Encrypted push to EHR/LIS systems or public-health dashboards.

Privacy by Design

Zero-Data architecture with no local PHI storage eases regulatory compliance.

Scalable SaaS Model

Per-scan fee model for test kit makers and healthcare payers.

Cost-Efficient Edge-AI

Reduced cloud expenses and enhanced performance in all conditions.

Accessible Webapp

No app download required, ensuring ease of use and maximum accessibility.

Defensible Intellectual Property

Our innovation is protected by a granted USA patent covering all claims, with several continuations submitted. National Phase applications are underway in multiple key territories, solidifying our unique and defensible position in the market.